PriceTargets.com logo

Aurora Cannabis - ACB Stock Price Target and Predictions

  • Consensus Rating: Strong Buy
  • Consensus Price Target: C$8.75
  • Forecasted Upside: 36.93%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 2 Strong Buy Ratings
C$6.39 As of 12/4/2025 05:00 PM ET
▲ +0.04 (0.63%)

This chart shows the closing price for ACB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aurora Cannabis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACB

Analyst Price Target is C$8.75
▲ +36.93% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Aurora Cannabis in the last 3 months. The average price target is C$8.75, with a high forecast of C$9.00 and a low forecast of C$8.50. The average price target represents a 36.93% upside from the last price of C$6.39.

This chart shows the closing price for ACB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Strong Buy

The current consensus among 2 polled investment analysts is to buy (strong buy) stock in Aurora Cannabis. This rating has held steady since June 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 2 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 2 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 2 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 2 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 2 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 2 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/5/2025Atb Cap MarketsUpgradeHold ➝ Strong-Buy
12/17/2024ATB CapitalLower TargetC$11.00 ➝ C$8.50
12/12/2024TD SecuritiesUpgradeStrong-Buy
12/11/2024TD SecuritiesSet TargetBuyC$9.00
6/21/2024ATB CapitalLower TargetSector PerformC$12.50 ➝ C$11.00
2/27/2024Jefferies Financial GroupLower TargetHoldC$6.12 ➝ C$4.95
2/21/2024CIBCLower TargetNeutralC$6.00
2/9/2024Canaccord Genuity GroupUpgradeHold ➝ BuyC$0.80
11/21/2023Jefferies Financial GroupLower TargetHoldC$0.69 ➝ C$0.61
11/16/2023CIBCLower TargetNeutralC$0.85 ➝ C$0.80
8/29/2023CIBCLower TargetNeutralC$1.00 ➝ C$0.85
8/11/2023CowenLower TargetC$1.00 ➝ C$0.80
6/22/2023Jefferies Financial GroupLower TargetC$1.31 ➝ C$0.72
6/16/2023CIBCLower TargetC$1.75 ➝ C$1.00
6/16/2023TD SecuritiesLower TargetC$1.30 ➝ C$1.00
6/15/2023Canaccord Genuity GroupLower TargetC$1.50 ➝ C$0.80
6/15/2023ATB CapitalLower TargetC$1.80 ➝ C$1.50
2/28/2023Jefferies Financial GroupLower TargetC$1.80 ➝ C$1.31
2/13/2023CIBCLower TargetNeutralC$2.25 ➝ C$1.75
2/13/2023Stifel NicolausLower TargetC$1.45 ➝ C$1.20
2/10/2023Canaccord Genuity GroupLower TargetC$2.00 ➝ C$1.50
1/27/2023Stifel NicolausLower TargetC$1.75 ➝ C$1.45
9/28/2022Jefferies Financial GroupLower TargetC$4.10 ➝ C$1.50
9/22/2022Stifel NicolausLower TargetC$2.15 ➝ C$1.75
9/22/2022ATB CapitalUpgradeUnderperform ➝ Sector PerformC$3.00 ➝ C$4.00
9/21/2022Atb Cap MarketsUpgradeUnderperform ➝ Sector Perform
9/21/2022Canaccord Genuity GroupUpgradeSell ➝ HoldC$2.50 ➝ C$2.00
9/21/2022Piper SandlerLower TargetNeutralC$4.00
9/19/2022CIBCLower TargetNeutralC$3.75 ➝ C$2.50
7/19/2022CowenBoost TargetC$1.85 ➝ C$2.00
7/19/2022CowenBoost TargetC$1.85 ➝ C$2.00
7/5/2022CowenLower TargetC$4.00 ➝ C$1.85
7/5/2022CowenLower TargetC$4.00 ➝ C$1.85
6/6/2022Stifel NicolausUpgradeSell ➝ HoldC$2.50 ➝ C$2.15
5/16/2022CowenLower TargetC$4.00
5/16/2022CIBCLower TargetC$6.50 ➝ C$3.75
5/16/2022CowenLower TargetC$7.00 ➝ C$4.00
5/13/2022Piper SandlerLower TargetHoldC$7.00 ➝ C$4.00
5/13/2022MKM PartnersReiterated RatingHoldC$6.50 ➝ C$3.00
5/10/2022ATB CapitalLower TargetUnderperformC$5.00 ➝ C$4.00
5/2/2022Stifel NicolausLower TargetC$3.50 ➝ C$3.00
2/11/2022Canaccord Genuity GroupLower TargetC$6.00 ➝ C$5.00
2/11/2022Piper SandlerReiterated RatingHoldC$5.00 ➝ C$7.00
2/11/2022MKM PartnersReiterated RatingHoldC$6.00 ➝ C$6.50
2/11/2022CowenLower TargetNeutralC$10.00 ➝ C$7.00
2/8/2022MKM PartnersLower TargetSellC$8.00 ➝ C$6.00
2/3/2022CIBCLower TargetC$9.25 ➝ C$6.50
11/12/2021MKM PartnersBoost TargetSellC$7.00 ➝ C$8.00
11/10/2021CowenBoost TargetC$10.00
11/10/2021CIBCUpgradeUnderperform ➝ HoldC$6.50 ➝ C$9.25
10/1/2021Jefferies Financial GroupReiterated RatingHold
9/30/2021Jefferies Financial GroupLower TargetNAC$8.56 ➝ C$7.50
9/30/2021CIBCLower TargetUnderperformC$7.00 ➝ C$6.50
9/29/2021ATB CapitalLower TargetSector PerformC$7.50 ➝ C$6.00
9/28/2021Piper SandlerReiterated RatingHoldC$7.00
9/24/2021CIBCReiterated RatingUnderperformC$7.00 ➝ C$6.50
9/23/2021CIBCLower TargetNAC$8.00 ➝ C$7.00
9/20/2021MKM PartnersLower TargetSellC$9.00 ➝ C$6.00
9/3/2021Jefferies Financial GroupUpgradeHoldC$9.44 ➝ C$6.78
7/23/2021Atb Cap MarketsReiterated RatingUnderperform
5/17/2021Stifel NicolausLower TargetNAC$7.80 ➝ C$6.50
5/17/2021CIBCLower TargetUnderperformC$9.00 ➝ C$8.00
5/14/2021CowenLower TargetNAC$16.00 ➝ C$8.50
5/14/2021MKM PartnersLower TargetNAC$9.00 ➝ C$6.00
5/14/2021ATB CapitalDowngradeSector Perform ➝ UnderperformC$13.00
5/13/2021Atb Cap MarketsDowngradeSector Perform ➝ Underperform
5/11/2021CIBCLower TargetNeutral ➝ UnderperformC$15.00 ➝ C$9.00
5/11/2021Royal Bank Of CanadaDowngradeUnderperform
2/24/2021Jefferies Financial GroupBoost TargetC$4.59 ➝ C$9.44
2/16/2021CIBCBoost TargetUnderperformC$18.50
2/12/2021MKM PartnersReiterated RatingSell
2/12/2021Stifel NicolausBoost TargetC$6.50 ➝ C$7.80
2/12/2021ATB CapitalBoost TargetSector PerformC$10.50 ➝ C$13.00
2/8/2021CIBCBoost TargetC$15.00 ➝ C$17.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.83 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 4 very positive mentions
  • 20 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 0 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Aurora Cannabis logo
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
Read More

Today's Range

Now: C$6.39
Low: C$6.32
High: C$6.48

50 Day Range

MA: C$6.97
Low: C$5.77
High: C$8.66

52 Week Range

Now: C$6.39
Low: C$4.95
High: C$9.90

Volume

309,285 shs

Average Volume

584,143 shs

Market Capitalization

C$359.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.006747

Frequently Asked Questions

What sell-side analysts currently cover shares of Aurora Cannabis?

The following Wall Street analysts have issued research reports on Aurora Cannabis in the last year: Atb Cap Markets, ATB Capital, and TD Securities.
View the latest analyst ratings for ACB.

What is the current price target for Aurora Cannabis?

0 Wall Street analysts have set twelve-month price targets for Aurora Cannabis in the last year. Their average twelve-month price target is C$8.75, suggesting a possible upside of 36.3%. TD Securities has the highest price target set, predicting ACB will reach C$9.00 in the next twelve months. ATB Capital has the lowest price target set, forecasting a price of C$8.50 for Aurora Cannabis in the next year.
View the latest price targets for ACB.

What is the current consensus analyst rating for Aurora Cannabis?

Aurora Cannabis currently has 2 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Strong Buy."
View the latest ratings for ACB.

What other companies compete with Aurora Cannabis?

Other companies that are similar to Aurora Cannabis include Cronos Group, Hydropothecary, DRI Healthcare Trust, Knight Therapeutics and Canopy Growth. Learn More about companies similar to Aurora Cannabis.

How do I contact Aurora Cannabis' investor relations team?

Aurora Cannabis' physical mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company's listed phone number is +1-604-3625207. The official website for Aurora Cannabis is auroramj.com. Learn More about contacing Aurora Cannabis investor relations.